proxyvotesnow.com

Home › Companies › Disc Medicine, Inc. › 2025-2026

Disc Medicine, Inc. 2025-2026 Proxy Voting Records

Compiled from SEC Form N-PX filings and Disc Medicine, Inc.’s Form 8-K, filed 2026-06-24 (Item 5.07 on EDGAR). Page generated 02 October 2026.

  • 5Ballot items
  • 221Asset managers
  • 1,347Fund votes
  • 2026-06-18Meeting date

Proxy season: 2024-2025 2025-2026

Explore Disc Medicine, Inc. in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by Disc Medicine, Inc.

These tallies are Disc Medicine, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2026-06-24 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

Disc Medicine, Inc. — official shareholder meeting results, meeting held 2026-06-18
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
Elect Director: Donald Nicholson, Ph.D. 28,559,799---- 5,347,4502,011,469 Majority: yes
Elect Director: John Quisel, J.D., Ph.D. 33,433,078---- 474,1712,011,469 Majority: yes
Elect Director: William White, M.P.P., J.D. 33,355,406---- 551,8432,011,469 Majority: yes
Proposal 2 - Approval, on a Non-Binding, Advisory Basis, of the Compensation Paid to the Company's Named Executive Officers The stockholders of the Company approved, on a non-binding, advisory basis, the compensation paid to the Company's n 33,528,449368,9709,830 --2,011,469 Majority: yes
Proposal 3: Ratification of Appointment of the Company's Independent Registered Public Accounting Firm The stockholders of the Company ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal y 35,908,9001,2988,520 ---- Majority: yes

Source: Disc Medicine, Inc., Form 8-K, filed with the SEC on 2026-06-24 — read the filing on EDGAR.

How asset managers voted at the Disc Medicine, Inc. 2025-2026 meeting

Each item below shows how the 221 asset managers that disclosed a Disc Medicine, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. TO APPROVE, ON A NON-BINDING, ADVISORY BASIS, THE COMPENSATION PAID TO THE COMPANY'S NAMED EXECUTIVE OFFICERS.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Combines 9 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 33,528,449AGAINST: 368,970

Disc Medicine, Inc.’s own tally for this item (“Proposal 2 - Approval, on a Non-Binding, Advisory Basis, of the Compensation Paid to the Company's Named Executive Officers The stockholders of the Company approved, on a non-binding, advisory basis, the compensation pai”): 33,528,449 for, 368,970 against, per its Form 8-K filed 2026-06-24 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 38,190,464 outstanding shares: 88% for, 1.0% against (89% of the company cast a for/against vote).

The 220 asset managers below cast 99.4% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the total votes cast at the meeting.

FOR 99.4%
FOR: 99.4%AGAINST: 0.6%ABSTAIN: 0.0%NOT VOTED: 0.0%
Largest asset managers voting on “TO APPROVE, ON A NON-BINDING, ADVISORY BASIS, THE COMPENSATION PAID TO THE COMPANY'S NAMED EXECUTIVE OFFICERS.” at Disc Medicine, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Fidelity11,331,3810 00For
T. Rowe Price2,370,5300 00For
Vanguard1,864,0751 00For
RA CAPITAL MANAGEMENT, L.P.1,577,1060 00For
Atlas Venture Life Science Advisors, LLC1,513,8750 00For
Frazier Life Sciences Management, L.P.1,354,8520 00For
BVF INC/IL1,272,3120 00For
State Street1,116,5281,047 00For
ORBIMED ADVISORS LLC1,064,8640 00For
BlackRock1,011,4102,317 810For
Siren, L.L.C.988,4010 00For
Wellington896,9840 00For
JPMorgan825,0350 00For
Woodline Partners LP767,3490 00For
GEODE CAPITAL MANAGEMENT, LLC623,4540 00For
Charles Schwab505,3450 00For
Vestal Point Capital, LP491,1100 00For
DEERFIELD MANAGEMENT COMPANY, L.P.479,7500 00For
Aberdeen474,6410 00For
Loomis Sayles473,5110 00For
Palo Alto Investors LP410,1210 00For
MUTUAL FUND SERIES TRUST399,2070 00For
Foresite Capital Management V, LLC374,0690 00For
PICTET ASSET MANAGEMENT SA346,5130 00For
JENNISON ASSOCIATES LLC318,6040 00For

Showing the 25 largest of 220 asset managers. See all 220 in the interactive database.

2. To elect each of the following Class III nominees to the Board of Directors as set forth below: Class III Nominees: Donald Nicholson, Ph.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

84% Majority: yes · of votes cast

FOR 84%WITHHELD 16%
FOR: 28,559,799WITHHELD: 5,347,450

Disc Medicine, Inc.’s own tally for this item (“Elect Director: Donald Nicholson, Ph.D.”): 28,559,799 for, 5,347,450 withheld, per its Form 8-K filed 2026-06-24 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 38,190,464 outstanding shares: 75% for, 14% withheld (89% of the company cast a for/withheld vote).

The 66 asset managers below cast 100% of the shares they voted on this item FOR (11,355,556 for, 0 against).

FOR 87%13%
FOR: 11,355,556 (87.3%)ABSTAIN: 1,646,218 (12.7%)
Largest asset managers voting on “To elect each of the following Class III nominees to the Board of Directors as set forth below: Class III Nomi” at Disc Medicine, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Fidelity5,922,0610 00For
Vanguard1,608,8630 4,3610For
T. Rowe Price976,6640 00For
JPMorgan824,9990 00For
State Street5880 795,2440Abstain
BlackRock460,8680 1,6070For
MUTUAL FUND SERIES TRUST395,2350 3,9720For
Charles Schwab252,6490 00For
Prudential/PGIM198,0210 1,2020For
Hartford186,1660 00For
Loomis Sayles00 172,9230Abstain
Dimensional00 165,2880Abstain
Jackson National105,0340 5,7270For
Northwestern Mutual88,5480 00For
Aberdeen00 86,1070Abstain
Victory Capital7410 83,6510Abstain
Brighthouse40,0970 39,3440For
BNY Mellon58,8050 9860For
Equitable58,0500 00For
TIAA00 49,2320Abstain
QUANTITATIVE MASTER SERIES LLC44,5030 00For
Columbia Threadneedle00 42,8920Abstain
AIG/SunAmerica00 36,0190Abstain
ALPS ETF Trust00 31,7140Abstain
ProShares00 29,0250Abstain

Showing the 25 largest of 66 asset managers. See all 66 in the interactive database.

3. To elect each of the following Class III nominees to the Board of Directors as set forth below: Class III Nominees: John Quisel, J.D., Ph.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 6 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 33,433,078WITHHELD: 474,171

Disc Medicine, Inc.’s own tally for this item (“Elect Director: John Quisel, J.D., Ph.D.”): 33,433,078 for, 474,171 withheld, per its Form 8-K filed 2026-06-24 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 38,190,464 outstanding shares: 88% for, 1% withheld (89% of the company cast a for/withheld vote).

The 66 asset managers below cast 100% of the shares they voted on this item FOR (12,823,418 for, 0 against).

FOR 99%
FOR: 12,823,418 (98.6%)ABSTAIN: 178,356 (1.4%)
Largest asset managers voting on “To elect each of the following Class III nominees to the Board of Directors as set forth below: Class III Nomi” at Disc Medicine, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Fidelity5,922,0610 00For
Vanguard1,610,3100 2,9140For
T. Rowe Price976,6640 00For
JPMorgan824,9990 00For
State Street794,7830 1,0490For
BlackRock462,4750 00For
MUTUAL FUND SERIES TRUST399,2070 00For
Charles Schwab252,6490 00For
Prudential/PGIM198,0210 1,2020For
Hartford186,1660 00For
Loomis Sayles172,9230 00For
Dimensional00 165,2880Abstain
Jackson National105,0340 5,7270For
Northwestern Mutual88,5480 00For
Aberdeen86,1070 00For
Victory Capital84,3920 00For
Brighthouse79,1230 3180For
BNY Mellon59,7910 00For
Equitable58,0500 00For
TIAA49,2320 00For
QUANTITATIVE MASTER SERIES LLC44,5030 00For
Columbia Threadneedle42,8920 00For
AIG/SunAmerica36,0190 00For
ALPS ETF Trust31,7140 00For
ProShares29,0250 00For

Showing the 25 largest of 66 asset managers. See all 66 in the interactive database.

4. To elect each of the following Class III nominees to the Board of Directors as set forth below: Class III Nominees: William White, M.P.P., J.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 6 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 33,355,406WITHHELD: 551,843

Disc Medicine, Inc.’s own tally for this item (“Elect Director: William White, M.P.P., J.D.”): 33,355,406 for, 551,843 withheld, per its Form 8-K filed 2026-06-24 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 38,190,464 outstanding shares: 87% for, 1% withheld (89% of the company cast a for/withheld vote).

The 66 asset managers below cast 100% of the shares they voted on this item FOR (12,821,981 for, 0 against).

FOR 99%
FOR: 12,821,981 (98.6%)ABSTAIN: 179,792 (1.4%)
Largest asset managers voting on “To elect each of the following Class III nominees to the Board of Directors as set forth below: Class III Nomi” at Disc Medicine, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Fidelity5,922,0610 00For
Vanguard1,608,8740 4,3500For
T. Rowe Price976,6640 00For
JPMorgan824,9990 00For
State Street794,7830 1,0490For
BlackRock462,4750 00For
MUTUAL FUND SERIES TRUST399,2070 00For
Charles Schwab252,6490 00For
Prudential/PGIM198,0210 1,2020For
Hartford186,1660 00For
Loomis Sayles172,9230 00For
Dimensional00 165,2880Abstain
Jackson National105,0340 5,7270For
Northwestern Mutual88,5480 00For
Aberdeen86,1070 00For
Victory Capital84,3920 00For
Brighthouse79,1230 3180For
BNY Mellon59,7910 00For
Equitable58,0500 00For
TIAA49,2320 00For
QUANTITATIVE MASTER SERIES LLC44,5030 00For
Columbia Threadneedle42,8920 00For
AIG/SunAmerica36,0190 00For
ALPS ETF Trust31,7140 00For
ProShares29,0250 00For

Showing the 25 largest of 66 asset managers. See all 66 in the interactive database.

5. TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2026.

AUDIT-RELATEDMajority of the votes cast: yes

Combines 2 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%
FOR: 35,908,900AGAINST: 1,298

Disc Medicine, Inc.’s own tally for this item (“Proposal 3: Ratification of Appointment of the Company's Independent Registered Public Accounting Firm The stockholders of the Company ratified the appointment of Ernst & Young LLP as the Company's independent registered”): 35,908,900 for, 1,298 against, per its Form 8-K filed 2026-06-24 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 38,190,464 outstanding shares: 94% for, 0.1% against (94% of the company cast a for/against vote).

The 66 asset managers below cast 100% of the shares they voted on this item FOR (13,001,456 for, 0 against).

FOR 99.9%
FOR: 13,001,456 (100.0%)ABSTAIN: 318 (0.0%)
Largest asset managers voting on “TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ” at Disc Medicine, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Fidelity5,922,0610 00For
Vanguard1,613,2240 00For
T. Rowe Price976,6640 00For
JPMorgan824,9990 00For
State Street795,8320 00For
BlackRock462,4750 00For
MUTUAL FUND SERIES TRUST399,2070 00For
Charles Schwab252,6490 00For
Prudential/PGIM199,2230 00For
Hartford186,1660 00For
Loomis Sayles172,9230 00For
Dimensional165,2880 00For
Jackson National110,7610 00For
Northwestern Mutual88,5480 00For
Aberdeen86,1070 00For
Victory Capital84,3920 00For
Brighthouse79,1230 3180For
BNY Mellon59,7910 00For
Equitable58,0500 00For
TIAA49,2320 00For
QUANTITATIVE MASTER SERIES LLC44,5030 00For
Columbia Threadneedle42,8920 00For
AIG/SunAmerica36,0190 00For
ALPS ETF Trust31,7140 00For
ProShares29,0250 00For

Showing the 25 largest of 66 asset managers. See all 66 in the interactive database.

Largest Disc Medicine, Inc. shareholders voting in 2025-2026

Ranked by the number of Disc Medicine, Inc. shares each manager voted on the most widely held ballot item of the 2025-2026 meeting, shown as a share of the 38,190,464 shares outstanding at the time of that meeting.

Top Disc Medicine, Inc. shareholders by shares voted, 2025-2026
#Asset manager % of shares outstanding
1Fidelity 29.67%
2T. Rowe Price 6.21%
3Vanguard 4.88%
4RA CAPITAL MANAGEMENT, L.P. 4.13%
5Atlas Venture Life Science Advisors, LLC 3.96%
6Frazier Life Sciences Management, L.P. 3.55%
7BVF INC/IL 3.33%
8State Street 2.93%
9ORBIMED ADVISORS LLC 2.79%
10BlackRock 2.65%

Reported Disc Medicine, Inc. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

Disc Medicine, Inc. beneficial owners on record for the 2025-2026 proxy season
Holder % outstanding Disclosure
FMR (Fidelity) 14.63% 13F
FMR LLC 13.88% DEF14A
AI DMI LLC 7.90% DEF14A
BlackRock 5.95% 13F
RA Capital Management, L.P. 5.84% DEF14A
Vanguard Group 4.63% 13F
State Street 4.45% 13F
T. Rowe Price 4.06% 13F
JPMorgan Chase 3.59% 13F
Geode Capital 1.95% 13F

Percentages above are of 38,190,464 shares outstanding, as reported by Disc Medicine, Inc. on its Form 10-Q dated 2026-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Disc Medicine, Inc.’s 10-Q dated 2026-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At Disc Medicine, Inc.'s shareholder meeting held 2026-06-18, in the 2025-2026 proxy season, 221 asset managers reported how they voted on 5 ballot items in their SEC Form N-PX filings, covering 1,347 separate fund positions. On the most widely held item on that ballot — TO APPROVE, ON A NON-BINDING, ADVISORY BASIS, THE COMPENSATION PAID TO THE COMPANY'S NAMED… — FOR was 99% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: Disc Medicine, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2026-06-24.

Disc Medicine, Inc. proxy season coverage: 2024-2025 · 2025-2026 (this page).